Geftinat 250 mg Tablets

Geftinat 250 mg Tablets Specification

Dosage Form
Tablet

Salt Composition
Gefitinib 250 mg

Indication
Non-small cell lung cancer (NSCLC)

Feature
Tyrosine kinase inhibitor, used in targeted cancer therapy

Ingredients
Gefitinib and excipients

Application
Oral administration for oncology use

Physical Color/Texture
Light brown, film-coated tablet

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

Route of Administration
Oral

Strength
250 mg per tablet

Prescription Required
Yes

ATC Code
L01XE02

Packaging Type
Bottle of 30 tablets

Product Code
GEFTINAT

About Geftinat 250 mg Tablets

Our proficiency enables us to offer premium quality Geftinat 250 mg that is basically an anti-cancer medicine. This medicine blocks the signals through the epidermal growth factor receptor (EGFR) in target cells to treat or prevent non-small cell lung cancer. Sourced from the reliable vendors of the market, this medicine has the desired ingredients that are suitable to block the uncontrolled cell growth due to cancer. The offered Geftinat 250 mg is available with us in several packaging options to meet the specific demands of the clients.

Features:

Purity
Precise composition
Zero side-effects
Longer shelf life

Geftinat 250 mg

We are a prestigious trader, distributor, exporter and supplier of Geftinat 250 mg to our esteemed clients. It is an anti- cancer medicine for treating non-small cell lung cancer. It blocks signaling through the epidermal growth factor receptor (EGFR) in target cells, where there is uncontrolled cell growth. Geftinat 250 mg is composed of authentic ingredients under the medical guidance and supervision at our vendors' unit. It is available at highly pocket- friendly prices in the market.

Targeted Therapy for NSCLC

Geftinat 250 mg Tablets are specially designed for patients with non-small cell lung cancer (NSCLC), serving as a targeted cancer therapy. By inhibiting the tyrosine kinase enzyme, the medication disrupts cancer cell growth while minimizing damage to healthy tissue. This makes Gefitinib a significant advancement in oncology treatment protocols.

Proper Administration and Dosage

The tablets should be administered orally as prescribed by a healthcare provider, typically one tablet (250 mg) daily. Always follow the doctors advice on dosage and duration to optimize treatment effectiveness. Patients must not alter the dose or discontinue therapy without medical consultation.

Storage and Shelf Life

Maintain the effectiveness of Geftinat by storing the tablets in a cool, dry environment below 30C, protected from moisture and light. The product is stable for up to 24 months under these conditions, ensuring its reliability until the stated expiry date.

FAQs of Geftinat 250 mg Tablets:

Q: How should Geftinat 250 mg Tablets be taken?

A: Geftinat 250 mg Tablets should be taken orally, typically once daily, with or without food, exactly as prescribed by your healthcare provider. Swallow the tablet whole with water and do not crush or chew it.

Q: What is the main indication for Geftinat 250 mg Tablets?

A: This medication is indicated primarily for the treatment of non-small cell lung cancer (NSCLC), as part of a targeted therapy approach using the active ingredient Gefitinib.

Q: When should I start using Geftinat 250 mg Tablets?

A: Geftinat should only be started after receiving a prescription from your oncologist, who will determine if it is suitable for your specific type and stage of lung cancer.

Q: Where should Geftinat 250 mg Tablets be stored?

A: Store the tablets in their original bottle at a temperature below 30C, away from light and moisture. Do not refrigerate. Keep out of reach of children.

Q: What is the process for obtaining Geftinat 250 mg Tablets in India?

A: You must have a valid prescription from a licensed medical practitioner. The tablets are widely available through authorized dealers, exporters, and wholesalers across India.

Q: How does Geftinat 250 mg benefit patients with NSCLC?

A: Geftinat targets specific proteins involved in cancer cell growth, thereby inhibiting tumor progression and offering a focused therapeutic option with potentially fewer side effects compared to conventional chemotherapy.

Get Latest Price